Literature DB >> 24683535

Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.

Amy T Waldman1, Girish Hiremath2, Robert A Avery1, Amy Conger3, Stacy L Pineles4, Michael J Loguidice5, Lauren S Talman5, Kristin M Galetta5, Michael J Shumski6, James Wilson5, E'tona Ford2, Amy M Lavery6, Darrel Conger3, Benjamin M Greenberg3, Jonas H Ellenberg7, Elliot M Frohman3, Laura J Balcer8, Peter A Calabresi2.   

Abstract

BACKGROUND: Low-contrast letter acuity and optical coherence tomography (OCT) capture visual dysfunction and axonal loss in adult-onset multiple sclerosis (MS), and have been proposed as secondary outcome metrics for therapeutic trials. Clinical trials will soon be launched in pediatric MS, but such outcome metrics have not been well-validated in this population.
OBJECTIVES: To determine whether MS onset during childhood and adolescence is associated with measurable loss of visual acuity and thinning of the retinal nerve fiber layer (RNFL), whether such features are noted only in the context of clinical optic nerve inflammation (optic neuritis, ON) or are a feature of MS even in the absence of optic nerve relapses, and to define the optimal methods for such detection. STUDY
DESIGN: Cross-sectional study.
METHODS: Monocular and binocular high- and low-contrast letter acuity and contrast sensitivity were assessed in a cross-sectional cohort of children (ages 5 to 17 years) with MS (N=22 patients, 44 eyes; 8 patients with a history of ON) and disease-free controls (N=29 patients; 58 eyes) from three academic centers. Binocular summation was determined by calculating the number of letters correctly identified using the binocular score minus the better eye score for each visual test. RNFL thickness was measured using OCT (Stratus OCT-3). Results were analyzed in terms of "eyes" as: MS ON+, MS ON-, and control eyes. Generalized estimating equation (GEE) regression models were used to compare patients to controls.
RESULTS: Traditional high-contrast visual acuity scores did not differ between MS ON+, MS ON-, and controls eyes. MS ON+ eyes had decreased monocular (p<0.001) and decreased binocular (p=0.007) low-contrast letter acuity (Sloan 1.25% contrast charts) scores. Monocular visual acuity did not differ when comparing MS ON- and control eyes. The magnitude of binocular summation using low-contrast charts was similar for pediatric MS participants and controls and was not diminished in children with a history of ON. While the mean RNFL thickness for all MS eyes (103±17 μm) trended lower when compared to corresponding measures in control eyes (109±9 μm, p=0.085), we confirmed a highly significant reduction in mean RNFL thickness in MS eyes with a history of ON (86±22 μm, p<0.001). RNFL thickness of MS ON- eyes in pediatric MS patients (109±11 μm) did not differ from controls (p=0.994).
CONCLUSIONS: Low-contrast letter acuity detects subtle visual loss in MS patients with prior ON, consistent with incomplete recovery, a finding further supported by RNFL loss in ON affected eyes. In MS patients with prior unilateral ON, binocular acuity is decreased; however, the magnitude of binocular summation is preserved, unlike adult-onset MS who exhibit a reduced capacity for visual compensation in the context of unilateral injury. Also unlike findings in adult-onset MS, we did not demonstrate RNFL thinning in ON- eyes of children and adolescents with MS. Further validation is required to confirm whether neurodegeneration of visual pathways occurs in the absence of relapse, and thus whether OCT will serve as a sensitive metric for such pathology in the pediatric and adolescent MS context.

Entities:  

Keywords:  demyelinating disease; multiple sclerosis; optic neuritis; pediatric

Year:  2013        PMID: 24683535      PMCID: PMC3964624          DOI: 10.1016/j.msard.2013.10.008

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  28 in total

1.  New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis.

Authors:  L J Balcer; M L Baier; V S Pelak; R J Fox; S Shuwairi; S L Galetta; G R Cutter; M G Maguire
Journal:  Mult Scler       Date:  2000-06       Impact factor: 6.312

2.  Further developments in binocular summation.

Authors:  R Blake; M Sloane; R Fox
Journal:  Percept Psychophys       Date:  1981-09

3.  Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States.

Authors:  T Chitnis; B Glanz; S Jaffin; B Healy
Journal:  Mult Scler       Date:  2009-03-19       Impact factor: 6.312

4.  Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy.

Authors:  Malgorzata Siger; Krzysztof Dziegielewski; Lukasz Jasek; Marek Bieniek; Agnieszka Nicpan; Jerzy Nawrocki; Krzysztof Selmaj
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

5.  Appropriate statistical methods to account for similarities in binary outcomes between fellow eyes.

Authors:  J Katz; S Zeger; K Y Liang
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-04       Impact factor: 4.799

6.  Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.

Authors:  L J Balcer; M L Baier; J A Cohen; M F Kooijmans; A W Sandrock; M L Nano-Schiavi; D C Pfohl; M Mills; J Bowen; C Ford; F R Heidenreich; D A Jacobs; C E Markowitz; W H Stuart; G-S Ying; S L Galetta; M G Maguire; G R Cutter
Journal:  Neurology       Date:  2003-11-25       Impact factor: 9.910

7.  Incidence of acquired demyelination of the CNS in Canadian children.

Authors:  B Banwell; J Kennedy; D Sadovnick; D L Arnold; S Magalhaes; K Wambera; M B Connolly; J Yager; J K Mah; N Shah; G Sebire; B Meaney; M-E Dilenge; A Lortie; S Whiting; A Doja; S Levin; E A MacDonald; D Meek; E Wood; N Lowry; D Buckley; C Yim; M Awuku; C Guimond; P Cooper; F Grand'Maison; J B Baird; V Bhan; A Bar-Or
Journal:  Neurology       Date:  2009-01-20       Impact factor: 9.910

8.  Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset.

Authors:  E A Yeh; B Weinstock-Guttman; N Lincoff; J Reynolds; A Weinstock; N Madurai; N Agarwal; P Buch; M Karpinski; M Ramanathan
Journal:  Mult Scler       Date:  2009-05-22       Impact factor: 6.312

9.  Association of retinal and macular damage with brain atrophy in multiple sclerosis.

Authors:  Jan Dörr; Klaus D Wernecke; Markus Bock; Gunnar Gaede; Jens T Wuerfel; Caspar F Pfueller; Judith Bellmann-Strobl; Alina Freing; Alexander U Brandt; Paul Friedemann
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

10.  Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes.

Authors:  Jeffrey M Gelfand; Douglas S Goodin; W John Boscardin; Rachel Nolan; Ami Cuneo; Ari J Green
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

View more
  14 in total

1.  Retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in children with obesity.

Authors:  Selim Demir; Samet Özer; Sait Alim; Alper Güneş; Hüseyin Ortak; Resul Yılmaz
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

2.  Radiomic analysis of the optic nerve at the first episode of acute optic neuritis: an indicator of optic nerve pathology and a predictor of visual recovery?

Authors:  Michaela Cellina; Marta Pirovano; Matteo Ciocca; Daniele Gibelli; Chiara Floridi; Giancarlo Oliva
Journal:  Radiol Med       Date:  2021-01-03       Impact factor: 3.469

Review 3.  Applications of optical coherence tomography in pediatric clinical neuroscience.

Authors:  Robert A Avery; Raneem D Rajjoub; Carmelina Trimboli-Heidler; Amy T Waldman
Journal:  Neuropediatrics       Date:  2015-03-24       Impact factor: 1.947

4.  MRI of acute optic neuritis (ON) at the first episode: Can we predict the visual outcome and the development of multiple sclerosis (MS)?

Authors:  Michaela Cellina; Chiara Floridi; Cristina Rosti; Marcello Orsi; Marta Panzeri; Marta Pirovano; Matteo Ciocca; Giancarlo Oliva; Daniele Gibelli
Journal:  Radiol Med       Date:  2019-08-21       Impact factor: 3.469

5.  Binocular low-contrast letter acuity and the symbol digit modalities test improve the ability of the Multiple Sclerosis Functional Composite to predict disease in pediatric multiple sclerosis.

Authors:  Amy T Waldman; Salim Chahin; Amy M Lavery; Geraldine Liu; Brenda L Banwell; Grant T Liu; Laura J Balcer
Journal:  Mult Scler Relat Disord       Date:  2016-08-26       Impact factor: 4.339

6.  Longitudinal Change of Circumpapillary Retinal Nerve Fiber Layer Thickness in Children With Optic Pathway Gliomas.

Authors:  Robert A Avery; Avital Cnaan; Joel S Schuman; Carmelina Trimboli-Heidler; Chieh-Li Chen; Roger J Packer; Hiroshi Ishikawa
Journal:  Am J Ophthalmol       Date:  2015-07-29       Impact factor: 5.258

7.  Interocular Difference in Retinal Nerve Fiber Layer Thickness Predicts Optic Neuritis in Pediatric-Onset Multiple Sclerosis.

Authors:  Amy T Waldman; Leslie Benson; John R Sollee; Amy M Lavery; Geraldine W Liu; Ari J Green; Emmanuelle Waubant; Gena Heidary; Darrel Conger; Jennifer Graves; Benjamin Greenberg
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 3.042

Review 8.  Vision and vision-related outcome measures in multiple sclerosis.

Authors:  Laura J Balcer; David H Miller; Stephen C Reingold; Jeffrey A Cohen
Journal:  Brain       Date:  2014-11-28       Impact factor: 13.501

9.  Optical coherence tomography and visual evoked potentials in pediatric MS.

Authors:  Amy T Waldman; Grant T Liu; Amy M Lavery; Geraldine Liu; William Gaetz; Tomas S Aleman; Brenda L Banwell
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-06-05

Review 10.  Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.

Authors:  Laura J Balcer; Jenelle Raynowska; Rachel Nolan; Steven L Galetta; Raju Kapoor; Ralph Benedict; Glenn Phillips; Nicholas LaRocca; Lynn Hudson; Richard Rudick
Journal:  Mult Scler       Date:  2017-02-16       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.